Search

Press release

Successful lecture at the Crops & Chemicals Conference in Berlin

Berlin, 12-14th February 2014

Participants of the Crops & Chemicals Conference expressed great interest in a lecture given by Evonik on two prominent product groups from the area of agricultural chemistry.

In their talk, Rene Haensel, Group Leader Development Agro (EMEA), and Carsten Riedl, Market Manager Agro (EMEA), presented oil enhancers from the BREAK-THRU® OE product group, as well as copolymeric dispersing agents from the BREAK-THRU® DA product group.

Evonik’s BREAK-THRU® product portfolio enables customers in the agricultural industry to further develop and enhance their plant protection formulations.
The additives increase the bio delivery of the active ingredients in the application of plant protection products, thereby improving their effectiveness. This prevents active particles from crystalizing and, thanks to an improved spreading, enhances the wetting of the plants with the plant protection product. Both of these aspects lead to an increased uptake of the active ingredient in the leaf as well as a more efficient use of the plant protection agent.

With Evonik being the sole supplier of these exclusive additives, the audience’s interest in the presentation was accordingly high. Those present expressed particular praise for the speakers by rating the talk as one of the best at the conference.

The Crops & Chemicals Conference takes place in February every year in Berlin. The well-attended event, which attracted around 300 participants, has become one of the most important conferences in the plant protection industry.

Rene Haensel presenting the BREAK-THRU® OE product group

Rene Haensel presenting the BREAK-THRU® OE product group

Contact

Rene Haensel

Group Leader Development Agro (EMEA)

Carsten Riedl

Market Manager Agro (EMEA)

  • Company information

    Evonik, the creative industrial group from Germany, is one of the world leaders
    in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms.

    Evonik is active in over 100 countries around the world. In fiscal 2012 more than 33,000 employees generated sales of around €13.4 billion and an operating profit (adjusted EBITDA) of about €2.4 billion (excluding Real Estate in both cases).

  • Disclaimer

    In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.